Genmab — April 2018

[E_L]

that is a certainly much more easy to read I can't wait to see the Ofa results in MS

[Bulder]

After having enlarged the poster I think(!) it says the same about depletion of B-cells. But also that a reduction of CD4+ and CD8+ T-cells was transient and recovered at day 28(?). Also transient changes in granulocyte counts.

[E_L]

yes, also in that article from gentogen, here the link http://n.neurology.org/content/90/15_Supplement/P2.410

[jkj]

Er der abstrakt frigivelse til ASCO idag ?

[jkj]

Kun titler kan jeg sehttps://iplanner.asco.org/am2017/#/

[jkj]

og kun poster præsentationer kan jeg se.

[jkj]

Zymeworks er udvalgt til oral præsentation for deres ZW25, spændende canadisk biotekselskab som er værd at hold øje med.

[HenryAS]

Nordea skriver idag: Genmab kan komme i fokus efter solide Darzalex-salgstal for marts. Vi er positive på Genmab.

[jkj]

ja det er tydeligt at nordea har set dem og køber ind på dem, men ville nu være rart hvis vi andre også kendte dem.

[AaBforever]

Hvis Nordea har set tallene, så har A/B også.

[HenryAS]

Selve tallene oplyser de ikke iden meddelelse jeg har fået kun ovennævnte at de var solide

[E_L]

that is still 2017 jkj, but 2018 should be released today.

[E_L]

i think last year Genmab published an ASCO title list themselves, so i think i am going to be lazy and wait for that...

[jkj]

I hope your right EL, but how can zymeworks make a press release regarding ASCO and ZW25 if the titles are not public yet ?

[AaBforever]

A/B læser åbenbart tallene med andre briller på -:(

[AaBforever]

[OHW]

AB jeg tror ikke de tænker så meget!! De spiller på en generel og stor nedtur på aktiemarked som helhed og når det sker, er biotek blandt dem der falder mest.

[E_L]

I think they went a bit early with their press release and breached the embargo. i remember last year was available around 3 to 4PM

[E_L]

makes me feel like a real nerd remembering that

[Her_for_at_lære]

@OHW, skal vi ned og teste 970?